Non-CME/CE Industry
Neurology
This presentation reviews the ever-growing role of primary care providers in the treatment of tardive dyskinesia (TD). Practical considerations for the screening and assessment of TD in patients taking antipsychotics for mental health disorders will be highlighted. Finally, appropriate treatments for TD and the role of AUSTEDO XR in the treatment of TD will be discussed.
Teva Pharmaceuticals